Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00479531 · ClinicalTrials.gov registry record · Phase 3
Sequential Compression Devices for Treatment of Restless Legs Syndrome
A Phase 3 study, sponsored by Walter Reed Army Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
NCT00479531 is a Phase 3 study that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT00479531, a Phase 3 study, has completed, sponsored by Walter Reed Army Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if sequential compression devices (SCD) when worn for an hour per day by patients suffering from Restless Legs Syndrome (RLS) are helpful for the improvement of the RLS symptoms and sleep.
Interventions
- DEVICE AirCast Sequential Compression Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00479531
The ClinicalTrials.gov registry entry for NCT00479531 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed Army Medical Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AirCast Sequential Compression Device is the first listed.
NCT00479531 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00479531 about?
NCT00479531 is a clinical study titled "Sequential Compression Devices for Treatment of Restless Legs Syndrome". The purpose of this study is to determine if sequential compression devices (SCD) when worn for an hour per day by patients suffering from Restless Legs Syndrome (RLS) are helpful for the improvement of the RLS symptoms and sleep.
What is the current status of trial NCT00479531?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2005-09. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00479531?
The interventions under investigation include: AirCast Sequential Compression Device (DEVICE).
Who is sponsoring clinical trial NCT00479531?
This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.